Dimensional Fund Advisors LP Boosts Stake in GE HealthCare Technologies Inc. $GEHC

Dimensional Fund Advisors LP increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,362,717 shares of the company’s stock after purchasing an additional 438,439 shares during the quarter. Dimensional Fund Advisors LP owned approximately 1.18% of GE HealthCare Technologies worth $402,647,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Varenne Capital Partners acquired a new stake in GE HealthCare Technologies in the third quarter worth about $1,241,000. Cresset Asset Management LLC lifted its holdings in shares of GE HealthCare Technologies by 10.5% in the 3rd quarter. Cresset Asset Management LLC now owns 8,619 shares of the company’s stock valued at $647,000 after buying an additional 817 shares during the period. Teachers Retirement System of The State of Kentucky boosted its position in GE HealthCare Technologies by 19.7% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 352,124 shares of the company’s stock worth $26,445,000 after purchasing an additional 58,000 shares in the last quarter. Mathes Company Inc. boosted its holdings in GE HealthCare Technologies by 2.0% during the third quarter. Mathes Company Inc. now owns 47,354 shares of the company’s stock worth $3,556,000 after buying an additional 907 shares in the last quarter. Finally, Focus Partners Advisor Solutions LLC purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth about $362,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 1.1%

GEHC opened at $79.02 on Thursday. The business has a fifty day moving average price of $82.12 and a 200 day moving average price of $78.54. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $89.77. The stock has a market capitalization of $36.01 billion, a price-to-earnings ratio of 17.33, a PEG ratio of 1.72 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter in the previous year, the firm earned $1.45 earnings per share. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be issued a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on GEHC. Citigroup increased their target price on GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. The Goldman Sachs Group restated a “buy” rating and set a $98.00 target price on shares of GE HealthCare Technologies in a report on Friday, January 9th. Piper Sandler upped their price objective on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, January 30th. Barclays increased their price objective on GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Finally, Stifel Nicolaus increased their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a research note on Wednesday, February 4th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies has an average rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.